Drug-induced liver injury (DILI) is an adverse reaction to drugs or other xenobiotics that
occurs either as a predictable event when an individual is exposed to toxic doses of some …

OBJECTIVES: Although drug-induced liver injury (DILI) is rare, it may result in significant
morbidity or death. The causes and outcome vary according to regions, with acetaminophen …

Drug-induced liver injury (DILI) is a minor but significant cause of liver injury across all regions.
Antituberculosis drug-induced liver injury (TB DILI) is a leading cause of DILI and drug-…

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular carcinoma…

The first consensus report of the working party of the Asian Pacific Association for the Study
of the Liver (APASL) set up in 2004 on acute-on-chronic liver failure (ACLF) was published in …

Liver disease accounts for two million deaths annually and is responsible for 4% of all deaths
(1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths …

Antimicrobial agents including antituberculosis (anti-TB) agents are the most common cause
of idiosyncratic drug-induced liver injury (DILI) and drug-induced liver failure across the …

Idiosyncratic drug-induced liver injury (DILI) is an important cause of morbidity and mortality
following drugs taken in therapeutic doses. Hepatotoxicity is a leading cause of attrition in …

Idiosyncratic drug-induced liver injury mimics acute and chronic liver disease. It is under
recognized and underrecognised because of the lack of pathognomonic diagnostic serological …

Sir William Osler, the renowned physician and one of the founding professors of Johns
Hopkins Hospital once remarked, Bthe desire to take medicine is perhaps the greatest feature …